TRON-Mainz, established in 2010 and headquartered in Germany, operates at the intersection of Biotechnology and Health and Wellness. The company's mission is encapsulated in its slogan: "Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges."
TRON-Mainz is a non-profit research institute dedicated to converting scientific breakthroughs into patient progress. The institute focuses on creating new diagnostics and treatments targeting cancer and other diseases with high medical need. By bridging fundamental science from universities and market-oriented pharmaceutical research, TRON-Mainz speeds up the journey from innovation to clinical testing.
With expertise in genomics and immunology, the company identifies “omics”-based biomarkers to develop personalized therapies. Their collaborations with academic institutions and industry players facilitate cutting-edge research in drug design. As of now, TRON-Mainz has not disclosed any recent investment activities.